October 11, 2022 Markets targeted by Isolde and Emanuel: Silquent’s characteristics: dna sequencing gene based diagnosis to hospitals high fixed costs on research equipments — so sell… Continue Reading
Interviews & Market Size October 11, 2022 Interview insights: I interviewed two homeowners in SF and asked them about their opinions on driving and parking in SF, and their opinions on… Continue Reading
Market sizing and interviewing for Special Needs market October 11, 2022 We estimated the market size for our research on the treatment of autistic spectrum disorders to be $2 billion for SAM, $2 billion for… Continue Reading
Interviews + Market October 10, 2022 For my interviews, I interviewed two Stanford undergraduate students (Nadine and Sarah) and a Notre Dame undergraduate student (Ian). I thought it was important… Continue Reading
Protected: Market Research, TAM/SAM/SOM October 10, 2022 There is no excerpt because this is a protected post. Continue Reading
Market size and attitude October 10, 2022 Product Description: An app that translates legal English into simplified common phrases, which can then be translated into other languages. Market Overview: Because our… Continue Reading
CASE STUDY: Can One Business Unit Have Two Revenue Models? October 10, 2022 Isolde, head of Siiquent, sells equipment to hospitals and big diagnostic labs for gene-based diagnosis. Emanuel, head of Teomik sells equipment to research labs… Continue Reading
Can two business models survive? October 10, 2022 Which markets do Isolde and Emanuel target respectively? How do their respective business/revenue models align with their markets? Isolde targets customers who are constrained… Continue Reading
Can One Business Unit Have Two Revenue Models? October 10, 2022 Before the merger, Isolde ran Siiquent, which sold the “stuff” that hospitals and diagnostic labs required for gene-based diagnosis. On the other hand, Emanuel… Continue Reading
